Patients may have questions when they pick up their prescription of Fiasp®. Here are some things you may want to discuss with them.
What is Fiasp®?
Fiasp® is a rapid-acting human insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus.
Fiasp® and NovoLog® have the same generic name, insulin aspart 100 U/mL, so be sure to confirm the brand name if it isn’t specified on the written script or in the ePrescribing system.